These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 17627167

  • 1. Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma.
    Merseburger AS, Hennenlotter J, Stenzl A, Beger G, Rinnab L, Kuczyk MA, Kuefer R.
    Urol Int; 2007; 79(1):41-3. PubMed ID: 17627167
    [Abstract] [Full Text] [Related]

  • 2. Cathepsin D expression in renal cell cancer-clinical implications.
    Merseburger AS, Hennenlotter J, Simon P, Ohneseit PA, Kuehs U, Kruck S, Koch E, Vogel U, Stenzl A, Kuczyk MA.
    Eur Urol; 2005 Sep; 48(3):519-26. PubMed ID: 16115525
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
    Feng G, Li G, Gentil-Perret A, Tostain J, Genin C.
    Anticancer Res; 2008 Sep; 28(1A):321-6. PubMed ID: 18383864
    [Abstract] [Full Text] [Related]

  • 4. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
    Singh KJ, Singh SK, Suri A, Vijjan V, Goswami AK, Khullar M.
    Indian J Cancer; 2005 Sep; 42(4):197-200. PubMed ID: 16391438
    [Abstract] [Full Text] [Related]

  • 5. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay.
    Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, Mani JC, Rochefort H.
    Cancer; 1997 Jun 01; 79(11):2132-6. PubMed ID: 9179059
    [Abstract] [Full Text] [Related]

  • 6. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW, Petri E, Bichler KH, Feil G.
    Anticancer Res; 1999 Jun 01; 19(4A):2583-90. PubMed ID: 10470199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
    Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Loening SA, Jung K.
    Cancer Lett; 2008 Sep 28; 269(1):85-92. PubMed ID: 18504068
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
    Schips L, Dalpiaz O, Lipsky K, Langner C, Rehak P, Puerstner P, Pummer K, Zigeuner R.
    Eur Urol; 2007 Jan 28; 51(1):168-73; discussion 174. PubMed ID: 16844285
    [Abstract] [Full Text] [Related]

  • 10. Tissue polypeptide specific antigen (TPS) as a tumor marker in renal cell carcinoma.
    Chang CH, Wu HC, Yen RF, Kao A, Lin CC, Lee CC.
    Anticancer Res; 2002 Jan 28; 22(5):2949-50. PubMed ID: 12530023
    [Abstract] [Full Text] [Related]

  • 11. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
    Karakiewicz PI, Hutterer GC, Trinh QD, Jeldres C, Perrotte P, Gallina A, Tostain J, Patard JJ.
    Cancer; 2007 Sep 15; 110(6):1241-7. PubMed ID: 17639589
    [Abstract] [Full Text] [Related]

  • 12. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF.
    Cancer Lett; 2009 Sep 18; 282(2):205-13. PubMed ID: 19362769
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K.
    Hepatogastroenterology; 2008 Sep 18; 55(82-83):388-93. PubMed ID: 18613372
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
    Kawata N, Yamaguchi K, Hirakata H, Hachiya T, Yoshida T, Takimoto Y.
    Urology; 2005 Oct 18; 66(4):736-40. PubMed ID: 16230127
    [Abstract] [Full Text] [Related]

  • 18. Value of procollagen type 1 amino-terminal propeptide in patients with renal cell carcinoma.
    Klepzig M, Sauer-Eppel H, Jonas D, Oremek GM.
    Anticancer Res; 2008 Oct 18; 28(4C):2443-6. PubMed ID: 18751432
    [Abstract] [Full Text] [Related]

  • 19. Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.
    Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Skrk J.
    Neoplasma; 2001 Oct 18; 48(1):66-71. PubMed ID: 11327540
    [Abstract] [Full Text] [Related]

  • 20. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
    Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, Hayakawa M.
    Jpn J Clin Oncol; 2008 Feb 18; 38(2):106-11. PubMed ID: 18245516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.